546 related articles for article (PubMed ID: 25500317)
21. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA.
Moreno-Mayordomo R; Ruiz M; Pascual J; Gallego de la Sacristana M; Vidriales I; Sobrado M; Cernuda-Morollon E; Gago-Veiga AB; Garcia-Azorin D; Telleria JJ; Guerrero AL
J Headache Pain; 2019 Apr; 20(1):39. PubMed ID: 31014225
[TBL] [Abstract][Full Text] [Related]
22. A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.
Winner PK; Kabbouche M; Yonker M; Wangsadipura V; Lum A; Brin MF
Headache; 2020 Mar; 60(3):564-575. PubMed ID: 32037549
[TBL] [Abstract][Full Text] [Related]
23. Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
Santoro A; Fontana A; Miscio AM; Zarrelli MM; Copetti M; Leone MA
Neurol Sci; 2017 Oct; 38(10):1779-1789. PubMed ID: 28726049
[TBL] [Abstract][Full Text] [Related]
24. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.
Ahmed F; Gaul C; García-Moncó JC; Sommer K; Martelletti P;
J Headache Pain; 2019 Mar; 20(1):26. PubMed ID: 30845917
[TBL] [Abstract][Full Text] [Related]
25. Development of onabotulinumtoxinA for chronic migraine.
Whitcup SM; Turkel CC; DeGryse RE; Brin MF
Ann N Y Acad Sci; 2014 Nov; 1329():67-80. PubMed ID: 25399521
[TBL] [Abstract][Full Text] [Related]
26. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
Mathew NT; Jaffri SF
Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
[TBL] [Abstract][Full Text] [Related]
27. Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation.
Bendtsen L; Sacco S; Ashina M; Mitsikostas D; Ahmed F; Pozo-Rosich P; Martelletti P
J Headache Pain; 2018 Sep; 19(1):91. PubMed ID: 30259200
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
29. Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.
Diener HC; Dodick DW; Lipton RB; Manack Adams A; DeGryse RE; Silberstein SD
Pain Ther; 2020 Dec; 9(2):683-694. PubMed ID: 33026631
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study.
Winner PK; Blumenfeld AM; Eross EJ; Orejudos AC; Mirjah DL; Adams AM; Brin MF
Drug Saf; 2019 Aug; 42(8):1013-1024. PubMed ID: 31102144
[TBL] [Abstract][Full Text] [Related]
31. The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
Silberstein SD; Diener HC; Dodick DW; Manack Adams A; DeGryse RE; Lipton RB
Pain Ther; 2020 Dec; 9(2):695-707. PubMed ID: 33026630
[TBL] [Abstract][Full Text] [Related]
32. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
Negro A; Curto M; Lionetto L; Martelletti P
J Headache Pain; 2015; 17():1. PubMed ID: 26792662
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK.
Batty AJ; Hansen RN; Bloudek LM; Varon SF; Hayward EJ; Pennington BW; Lipton RB; Sullivan SD
J Med Econ; 2013 Jul; 16(7):877-87. PubMed ID: 23647483
[TBL] [Abstract][Full Text] [Related]
34. OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients.
Miller S; Correia F; Lagrata S; Matharu MS
J Headache Pain; 2015 Mar; 16():19. PubMed ID: 25902798
[TBL] [Abstract][Full Text] [Related]
35. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.
Hepp Z; Rosen NL; Gillard PG; Varon SF; Mathew N; Dodick DW
Cephalalgia; 2016 Aug; 36(9):862-74. PubMed ID: 26692400
[TBL] [Abstract][Full Text] [Related]
37. FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
Rothrock JF; Adams AM; Lipton RB; Silberstein SD; Jo E; Zhao X; Blumenfeld AM;
Headache; 2019 Nov; 59(10):1700-1713. PubMed ID: 31559634
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
39. Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.
Blumenfeld AM; Tepper SJ; Robbins LD; Manack Adams A; Buse DC; Orejudos A; D Silberstein S
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):353-360. PubMed ID: 30630956
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
